NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) hit a new 52-week high on Wednesday . The company traded as high as C$5.74 and last traded at C$5.69, with a volume of 173207 shares trading hands. The stock had previously closed at C$5.67.
Analyst Upgrades and Downgrades
NWH.UN has been the subject of a number of research analyst reports. Scotiabank raised their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. BMO Capital Markets raised their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research note on Thursday, November 13th. CIBC upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research note on Thursday, November 13th. Finally, Royal Bank Of Canada set a C$5.50 target price on shares of NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a report on Monday, November 24th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of C$6.00.
View Our Latest Research Report on NWH.UN
NorthWest Health Prop Real Est Inv Trust Stock Up 0.9%
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) last released its quarterly earnings data on Tuesday, November 11th. The company reported C$0.06 earnings per share for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The company had revenue of C$110.69 million for the quarter. On average, sell-side analysts forecast that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current year.
About NorthWest Health Prop Real Est Inv Trust
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
Read More
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- Your Signature Is Missing – Act Before It’s Too Late
- This coin has everything going for it
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Buy this Gold Stock Before May 2026
- What Expenses Can Be Deducted From Capital Gains Tax?
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.
